Erkam Kocaaslan

9PUBLICATIONS
67CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Liquid biopsiesInnate immunityMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 15, 2026
Long-Term Outcomes and Conditional Recurrence-Free Survival in Stage II Colon Cancer: The Impact of Surveillance and Recurrence Detection Strategies.

|May 23, 2026
Development and internal validation of the CLIP-M score for advanced mucosal malignant melanoma: exploratory prognostic stratification and comparative assessment with the RMH score.

|May 08, 2026
Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients.

|Apr 14, 2026
Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab.

Gözde Ağdaş, Duygu Bayir, Elif Şahin

|Feb 21, 2026
The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer.

Muhammet Cengiz, Oktay Bozkurt, Ayşe Nuransoy Cengiz

|Jan 28, 2026
Prognostic Value of Systemic Immune-Inflammation Index in Mucosal Malignant Melanoma.

Burak Paçacı, Erkam Kocaaslan, Ahmet Demirel

Pageof 2

Frequent Collaborators

8 joint publications

Nargiz Majidova

5 joint publications

Ali Kaan Güren

5 joint publications

Fırat Akagündüz

5 joint publications

Mustafa Alperen Tunç